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Introduction
Modern clinical practice relies on the use of antibiotics 
to combat bacterial infections, yet our knowledge 
of how antibiotics inhibit bacteria is surprisingly 
incomplete. In particular, mathematical models are 
needed to translate known information about the 
molecular processes that are targeted by antibiotics 
into predictions for bacterial growth rate as a function 
of antibiotic concentration. Such models would allow 
optimisation of dosing regimes [1–3], and provide 
a basis for understanding the evolution of resistance 
to antibiotics [4–7]. Recent work has focused on 
predicting how bacterial growth responds to a fixed 
antibiotic concentration [2, 7–10]. Although in 
the clinic the antibiotic concentration to which 
an infection is exposed is time-varying, there has 
been little mechanistic modelling of the response of 
bacterial growth to a time-varying dose of antibiotic 
(for recent work in this direction see [11–13]). In 
this paper, we present theoretical predictions for the 
dynamical changes in bacterial growth rate in response 
to a time-varying concentration of a ribosome-
targeting antibiotic. Our analysis predicts qualitative, 
and potentially clinically relevant, differences in the 
dynamical response of bacterial growth to antibiotic 
treatment, depending on the molecular parameters 
for antibiotic-ribosome binding and transport of 
antibiotic across the bacterial cell boundary.
We focus here on antibiotics that target bacterial 
ribosomes. Ribosomes are multi-component, molec-
ular machines which carry out protein  synthesis—a 
function that is crucial for growth. Different ribosome-
targeting antibiotics can bind to different components 
of the bacterial ribosome and inhibit different steps 
in protein synthesis [14]. In recent experimental and 
theoretical work [8], we showed that some ribosome-
targeting antibiotics work better for bacteria that are 
growing rapidly (on a rich medium) while others work 
better for bacteria that are growing slowly (on a poor 
medium). These observations can be reproduced by 
a simple mathematical model that takes account of 
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Abstract
Understanding how antibiotics inhibit bacteria can help to reduce antibiotic use and hence avoid 
antimicrobial resistance—yet few theoretical models exist for bacterial growth inhibition by a 
clinically relevant antibiotic treatment regimen. In particular, in the clinic, antibiotic treatment 
is time-dependent. Here, we use a theoretical model, previously applied to steady-state bacterial 
growth, to predict the dynamical response of a bacterial cell to a time-dependent dose of ribosome-
targeting antibiotic. Our results depend strongly on whether the antibiotic shows reversible transport 
and/or low-affinity ribosome binding (‘low-affinity antibiotic’) or, in contrast, irreversible transport 
and/or high affinity ribosome binding (‘high-affinity antibiotic’). For low-affinity antibiotics, our 
model predicts that growth inhibition depends on the duration of the antibiotic pulse, and can 
show a transient period of very fast growth following removal of the antibiotic. For high-affinity 
antibiotics, growth inhibition depends on peak dosage rather than dose duration, and the model 
predicts a pronounced post-antibiotic effect, due to hysteresis, in which growth can be suppressed for 
long times after the antibiotic dose has ended. These predictions are experimentally testable and may 
be of clinical significance.
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the molecular processes of antibiotic-ribosome bind-
ing and antibiotic transport across the cell boundary, 
as well as the physiological processes of cell growth 
and ribosome synthesis [8]. Reference [8], however, 
considered only the response to a fixed (time-invari-
ant) antibiotic concentration. In the present paper, 
we extend the predictions of the model to the more 
clinically-relevant case of a time-dependent antibiotic 
dose.
Pharmacokinetic curves describe the time-varying 
local antibiotic concentration at an infection site dur-
ing a clinical treatment regime [15]. These curves show 
a peak, since the antibiotic concentration initially 
increases following ingestion, then later decreases due 
to metabolism and excretion [15, 16]. Pharmacody-
namics attempts to link these curves to the efficacy of 
antibiotic action [15, 16]. In particular, some dosing 
protocols are designed to maximise the peak concen-
tration, whereas others aim to maximise the time at 
which the concentration is maintained above a certain 
threshold, or, alternatively, the area of the curve which 
is above a threshold [15]. Importantly, for some antibi-
otics, activity can persist for some time after the anti-
biotic is removed: this is known as the post-antibiotic 
effect [17, 18] and occurs for a variety of antibiotics 
including ribosome-targeting aminoglycosides [18, 
19]. The mechanisms behind this effect are unknown 
but may include slow recovery after reversible dam-
age to cell structures, slow removal of the antibiotic 
from its binding site, and the need to synthesize new 
enzymes before a bacterium can resume growth [17].
In this paper, we use the mathematical model of 
ribosome-targeting antibiotics introduced in [8] 
to make dynamical predictions for the response of 
bacterial growth rate to a time-varying antibiotic 
concentration. The model predicts qualitatively dif-
ferent dynamical responses for ribosome-targeting 
antibiotics that bind to ribosomes with high affinity 
and/or are transported into the cell irreversibly (‘high-
affinity antibiotics’), as opposed to antibiotics that 
bind with low affinity and/or are transported revers-
ibly (‘low-affinity antibiotics’). Our results reproduce 
known pharmacodynamic phenomena, such as a post- 
antibiotic effect for high-affinity ribosome-targeting 
antibiotics. Our model also predicts new phenomena, 
including a transient increase in growth rate upon 
removal of a low-affinity ribosome-targeting antibi-
otic. We suggest ways in which these predictions could 
be tested experimentally and comment on their poten-
tial clinical relevance.
Background: mathematical model for the 
action of ribosome-targeting antibiotics
We first provide a brief description of the model which 
was introduced in [8]. The model aims to predict 
the growth inhibition curve: the growth rate λ of a 
bacterial population, as a function of the antibiotic 
concentration aex to which it is exposed. Here, the 
growth rate is defined by λ∼N t texp( ) ( ), where 
N t( ) is the number of bacteria at time t. The growth 
inhibition curve λ aex( ) is expected to be a decreasing 
function, which can be conveniently characterised by 
the concentration of antibiotic required to halve the 
growth rate, known as the IC50.
As illustrated in figure 1, the model describes a bac-
terial cell as homogeneous mixture of ribosomes and 
antibiotic molecules, which can bind reversibly to the 
ribosomes. The variables of the model are the concen-
trations of bound and unbound ribosomes, rb and ru 
respectively, and the concentration of intracellular 
antibiotic a. The model consists of the following set of 
equations for the dynamics of the concentrations:
λ= − − + −a F a r r a P a P a, , ,u b in ex out˙ ( ) (1)
λ= − − +r F a r r r s, , ,u u b u˙ ( ) (2)
λ= −r F a r r r, , .b u b b˙ ( ) (3)
Here, ≡ − −F a r r k a r r k r, ,u b on u min off b( ) ( )  describes 
the antibiotic-ribosome binding / unbinding kinetics. 
Pin and Pout are rate constants (or permeabilities) for 
antibiotic transport into and out of the cell (both 
assumed to be linear processes), and a tex( ) is the 
external antibiotic concentration, which can be 
controlled in a lab experiment, or is set by the dosing 
regime in a clinical scenario. The terms λ− a, λ− ru 
and λ− rb describe dilution of the cell contents by 
growth at rate λ. Finally, s is the rate of synthesis of new 
ribosomes.
To complete the model, we need to describe how 
the growth rate λ and the ribosome synthesis rate 
s depend on the state of the system (grey arrows in 
 figure 1). To do this, we use the empirical ‘growth 
laws’ of Scott et al [20, 21]. These are experimentally- 
established mathematical relations that describe 
how a bacterial cell balances the production of new 
ribosomes and of other proteins, depending on its 
growth rate. The first of these relations states that the 
Figure 1. Schematic illustration of the model. The bacterial 
cell is modelled as a well-mixed vessel, containing ribosomes 
(dark blue) which may be free or bound by antibiotic. 
Antibiotic molecules (black circles) can be transported into 
or out of the cell (pink arrow) and can bind to or dissociate 
from ribosomes (orange arrow). The model also includes cell 
growth (green) and ribosome synthesis (light blue), both of 
which are coupled to the state of the cell (these couplings are 
illustrated by the grey arrows).
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growth rate λ is linearly related to the concentration of 
unbound ribosomes ru:
λ
κ
= +r r .
t
u min (4)
Relation (4) is based on measurements in the absence 
of antibiotic [20, 22]; we assume here, as in [8], that it 
also holds in the presence of antibiotic6. The constant 
κ µ= × −6.1 10t 2    M −h 1 is the translation rate of the 
ribosomes and the constant µ=r 19.3min   M is believed 
to arise from an inactive pool of ribosomes which 
may be waiting to initiate translation or stalled during 
translation [20, 23]. We have implicitly assumed 
that these inactive ribosomes do not bind antibiotic, 
through our definition of the binding function 
F a r r, ,u b( )7.
The ribosome synthesis rate s can be deduced from 
the second ‘growth law’ of Scott et al, which states that 
the total ribosome content rtot is linearly related to the 
growth rate [20]:
⎛
⎝⎜
⎞
⎠⎟λ λ κ= −∆ − ∆r r r r
1 1
t
tot max
0 ( )
 (5)
where µ=r 65.8max   M is a universal maximal ribosome 
concentration [20], µ∆ = − =r r r 46.5max min   M is the 
dynamic range of the active ribosome concentration 
and λ0 is the bacterial growth rate in the absence of 
antibiotic. Equation (5) states that the total ribosome 
content increases as growth rate decreases due to 
ribosome inhibition: this is because of up-regulation of 
ribosome synthesis [24–26]. However, the slope of this 
increase depends on how fast the cells were growing 
before they were inhibited (i.e. on λ0). Fast-growing 
cells, in a rich growth medium, increase their ribosome 
content proportionally less than slow-growing cells, in 
a poor growth medium, do. Intuitively, fast-growing 
cells, which have a high ribosome content, already 
need to devote close-to-maximal protein production 
capacity to ribosome production so cannot increase 
ribosome synthesis further upon antibiotic challenge. 
In contrast, slow-growing cells, which have lower 
ribosome content, have excess protein production 
capacity that can be diverted to ribosome synthesis. In 
our model the total ribosome concentration is given 
by = +r r rtot u b. For cells growing exponentially, the 
contents of the cell are in a steady state, and thus the 
rate of ribosome synthesis must match the rate of 
ribosome removal by dilution: λ=s rtot. This leads 
to a quadratic expression for the synthesis rate s as a 
function of λ:
⎡
⎣⎢
⎛
⎝⎜
⎞
⎠⎟
⎤
⎦⎥λ λ λ λ κ= − ∆ − ∆s r r r
1 1
.
t
max
0
( )
( ) (6)
Equations (1)–(3) together with (4) and (6) constitute 
a complete description of the model8.
Reference [8] focused on the stationary points of 
the system of equations (1)–(3), (4) and (6). Briefly, 
setting the time derivatives in equations (1)–(3) to 
zero: = = =a r r 0u b˙ ˙ ˙ , using equation (4) to eliminate 
ru in favour of λ, then using equation (3) to eliminate rb 
in equations (1) and (2) leads to two independent rela-
tions between a and λ, which can be solved to eliminate 
a. This leads finally to a cubic equation for the station-
ary points of the growth rate λ9:
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
⎡
⎣⎢
⎛
⎝⎜
⎞
⎠⎟
⎤
⎦⎥
⎛
⎝⎜
⎞
⎠⎟
⎡
⎣
⎢⎢
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎤
⎦
⎥⎥
λ
λ
λ
λ
κ
λ
λ
κ λ
λ
κ λ
λ
= − +
+ +
−
+
∗
∗
∗
k
k
P k
P k k
0 1
1
2
t
t
t
0
3
0
0
2
on
0
2
on
0
0
2
out off
out off on
0
0
⎛
⎝⎜
⎞
⎠⎟
⎡
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⎢⎢
⎛
⎝
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⎞
⎠
⎟⎟
⎛
⎝⎜
⎞
⎠⎟
⎛
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⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎤
⎦
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λ
λ
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λ
λ
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+
+
− − +∗ ∗ ∗
P k
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2 2IC
1
4
1
4
,t
0
out off
out off on
0
0
ex
50
0
0
 (7)
where =K k kD off on/  and we have defined the 
parameter combinations λ κ=∗ P K2 t0 out D and 
λ= ∆∗ ∗ r PIC 250 0 in/( ).
If the effective parameter λ∗0 is large, corresponding 
to reversible antibiotic transport and/or low-affinity 
binding (large values of Pout and/or =K k kD off on/ ), 
then equation (7) has a single fixed point for any given 
value of aex, as illustrated in figure 2(a). This corre-
sponds to a smoothly decreasing growth inhibition 
curve, as observed experimentally in [8] for the anti-
6 The conversion between the units of fraction of cell mass 
used in [20] and ribosome concentration is discussed in the 
supplementary material of [8].
7 The assumption that inactive ribosomes do not bind 
antibiotic simplifies the mathematical analysis; numerical 
investigations confirm that the qualitative behaviour of the 
model is the same if the inactive ribosomes are allowed to 
bind to antibiotic.
8 It is useful to comment on two points regarding the biological 
interpretation of this model. First, over times shorter than the 
bacterial generation time, the model describes an exponentially 
growing bacterial cell. To see this, we note that if the cell is 
growing exponentially, then its volume increases as λ=V V˙ . 
Assuming that molecules of a particular type are produced at 
a rate proportional to the volume, we obtain =N gV˙  for the 
molecule number N, where g is a production rate constant. 
The dynamics of the molecular concentration =n N V/  
is then given by λ= − = −n V N N V V g n1 2˙ ( / ) ˙ ( / ) ˙ , as in 
equations (1)–(3). Second, over times longer than the bacterial 
generation time, the model describes the behaviour of a 
lineage of cells. Bacterial cells undergo periodic division 
events; however, these events do not (on average) change 
the molecular concentrations, because both the molecule 
number and the cell volume are (on average) halved. Thus our 
model effectively describes an experiment in which we follow 
the dynamics of the molecular concentrations within an 
individual bacterial cell as it grows and divides, and in which, 
at each division event, we follow only one of the daughter cells.
9 For details of this calculation see the supplementary 
material of [8].
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biotics chloramphenicol and tetracycline. In contrast, 
if the parameter λ∗0 is small, corresponding to irrevers-
ible transport and/or high-affinity binding (small 
values of Pout and/or =K k kD off on/ ), then the model 
solution has 3 fixed points for values of aex below a 
critical threshold, which is a bifurcation point (figure 
2(b)). The upper and lower fixed points are stable sinks 
and the intermediate fixed point is an unstable saddle 
point of the dynamics. For example, for the param-
eter set of figure 2(b), for = ×a 0.9ex   IC50 (below the 
bifurcation point), the real parts of the eigenvalues 
of the Jacobean matrix at the three fixed points are 
− × − − − × −1.1 10 , 0.66, 0.90 , 5.7 10 , 0.89, 0.34 ,4 3( ) ( )  
( )− × − × − ×− −1.0 10 , 1.0 10 , 2.7 106 3 5 . Thus, the 
first and third fixed points are stable (their eigenvalues 
have all negative real parts) while the second fixed point 
is unstable (it has an eigenvalue with a postive real part). 
For = ×a 1.1ex   IC50 (above the bifurcation point), the 
single fixed point has eigenvalues with all negative 
real parts − × − × − ×− −1.3 10 , 1.0 10 , 2.2 106 2 5( ) 
- i.e. it is stable. The bifurcation points of the model 
are discussed in more detail in appendix A, where it is 
also argued that the value λ= ∆∗a r P4ex 0 in/( ) is a good 
approximation for the (upper) bifurcation point. 
From a practical point of view, if λ∗0 is small, then for 
small values of the external antibiotic concentra-
tion, we expect to observe little inhibition of bacte-
rial growth, corresponding to the upper fixed point of 
the dynamics. However, for antibiotic concentrations 
above the bifurcation point, we expect to see drastic 
growth inhibition, corresponding to the single (lower) 
fixed point. This implies a steep, threshold-like growth 
inhibition curve, as observed experimentally in [8] for 
the aminoglycosides streptomycin and kanamycin10.
Equation (7) can also be used to derive a simple 
expression for the dependence of the IC50 on λ0 [8]:
⎡
⎣
⎢⎢
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎤
⎦
⎥⎥
κ λ
λ
λ
λ
κ
= + +
+
+
∗ ∗
∗
k
P k
P k k
IC
IC
1
2
1
.
t
t
50
50 on
0
0
0
0
out off
out off on
( )
 
(8)
Equation (8) predicts that antibiotic efficacy will 
increase with nutrient richness (IC50 decreases with 
λ0) when λ∗0 is large, but that efficacy will decrease with 
nutrient richness (IC50 increases with λ0) when λ∗0 is 
small. These predictions, which are in agreement with 
experimental data, were discussed in detail in [8].
Results: model predictions for dynamical 
response to antibiotic
In a clinical context, antibiotic concentrations vary 
in time. In this paper, we explore the predictions of 
the model defined by equations (1)–(3), (4) and (6), 
for the response of bacterial growth rate to a time-
dependent exposure to antibiotic—i.e. we explore 
the dynamics a t( ), r tu( ) and r tb( ) for a time-varying 
external antibiotic concentration a tex( ). In most cases 
(with some exceptions that we discuss below), these 
equations are not amenable to an analytical solution in 
the time-varying case. We therefore integrate the model 
equations numerically, starting from the steady-state 
solution in the absence of antibiotic11. We compare 
results for two sets of parameters, representing 
antibiotics which are bound and transported with ‘low 
affinity’ (high values of P Pout in/  and k koff on/ ) and with 
‘high affinity’ (low values of P Pout in/  and k koff on/ ). These 
parameters, which are chosen to be within the range 
Figure 2. Fixed points of the model, from equation (7), plotted as a function of the external antibiotic concentration aex, for the 
two parameter sets given in table 1, corresponding to antibiotics with large and small values of λ∗0. Panel (a) shows results for a low-
affinity antibiotic, with a large value of λ∗0 (table 1). Panel (b) shows results for a high-affinity antibiotic, with a small value of λ
∗
0  
(table 1). The fixed points were obtained numerically in Python using sympy.solvers.solve. The external antibiotic concentration is 
scaled by the IC50 value calculated from equation (8) and given in table 1.
10 It is important to recognise that streptomycin and 
kanamycin have other physiological effects, not included in 
our model, such as production of misfolded protein which 
may affect membrane permeability [35].
11 All numerical solutions of the system of ordinary 
differential equations described in this paper were carried 
out in python using www.scipy.integrate.odeint.
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of literature values for tetracycline and streptomycin 
respectively12, are listed in table 1.
It is important to note that the growth laws that we 
use in our model, equations (4) and (6), are derived 
from experimental measurements on exponentially 
growing bacteria, for which all intracellular concentra-
tions are in steady state. In using these constraints to 
make predictions for dynamical trajectories we assume 
that the cell adjusts its rates of growth and ribosome 
synthesis rapidly in response to changing external con-
ditions, in comparison to the rate at which the external 
conditions vary. It is known that the ribosome synthe-
sis rate can adjust within minutes to changes in nutri-
ent conditions [27]. A typical timescale for synthesis 
of a protein molecule is  ∼1 minute (∼1000 amino 
acids polymerised at a translation rate of  ∼20 amino 
acids per second [22]), while a conservative estimate 
for the timescale for synthesis of a ribosome is  ∼6 min 
(∼7500 amino acids in the entire ribosomal complex, 
produced at  ∼20 amino acids per second [22]). The 
timescale over which antibiotic concentration builds 
up in the body after an oral dose is  ∼30 minutes, with 
a slower decay time due to excretion [15]. The use of 
the steady-state constraints (4) and (6) therefore seems 
reasonable.
Response to a step increase in antibiotic
To analyse the dynamical behaviour of the model, 
we first consider the response to a sudden, step-like 
increase in antibiotic concentration, from zero to a 
fixed value: =a t 0ex( )  for <t t0 and =a t aex exfinal( )  for 
>t t0. In the clinical context, this would correspond to 
an intravenous infusion of antibiotic; in the laboratory 
it could be achieved using a continuous culture device 
[28, 29] or microfluidic flow device [30]).
Low-affinity antibiotic.
Figure 3 explores the dynamical response of the 
model to a step increase in concentration of a low-
affinity antibiotic. The model predicts a strikingly 
non-monotonic response of the bacterial growth 
rate λ λt 0( )/ , as shown in figure 3(a): we observe an 
initial rapid decrease in growth rate, followed by a 
slower recovery to a steady-state value that depends 
on the antibiotic concentration aex
final. This steady-
state value corresponds to the fixed point of the 
model dynamics (figure 2(a)). The origin of this non-
monotonic response can be understood by plotting the 
trajectory of the model in the 3d space of its variables 
a, ru and rb, as in figure 3(b). Following the increase 
in aex, the intracellular antibiotic concentration 
a rapidly increases, accompanied by a decrease in 
the concentration of unbound ribosomes and an 
increase in the concentration of bound ribosomes rb. 
These changes are driven by the rapid dynamics of 
antibiotic transport and binding/unbinding. The later, 
much slower, recovery of the growth rate observed in 
figure 3(a) corresponds to an increase in both ru and 
rb in the trajectory of figure 3(b) and is associated with 
the slower dynamics of ribosome synthesis in response 
to the antibiotic challenge. Thus, the non-monotonic 
response of the growth rate predicted by the model 
is due to the initial, rapid processes of transport and 
binding, followed by a slower partial recovery due to 
increased ribosome synthesis.
The dynamics of the model can also be illus-
trated in the form of a flow diagram, as in figure 3(c). 
Here, the arrows show the direction of the flow field 
r r,u b˙ ˙  for a fixed value of a, while the solid line shows 
the nullcline =r 0u˙ . The trajectory of figure 3(b) is 
shown projected onto this plane. This diagram illus-
trates clearly the separation of timescales between 
transport and binding, which produces a strong flow 
field towards the centre of the diagram, and ribosome 
synthesis, which is responsible for the slower dynamics 
along the nullcline as the system approaches the stable 
fixed point.
High-affinity antibiotic.
The model predictions are strikingly different for the 
high-affinity antibiotic (figure 4). The bacterial growth 
rate (figure 4 (a)) is predicted to decrease smoothly 
and monotonically for low antibiotic concentrations 
aex
final, as it approaches the upper fixed point in 
figure 2(b). However, for antibiotic concentrations 
aex
final that are above the bifurcation point in figure 2(b) 
the model predicts instead a decline in growth rate 
to a state in which there is essentially no growth. 
The timescale of this approach to the non-growing 
steady state can be very long (of the order of days) 
for antibiotic concentrations close to the bifurcation 
point.
Plotting the dynamics of the model in the 3d space 
of its variables (figure 4(b)) illustrates the very different 
Table 1. Parameter values used in this study to model low and high-
affinity ribosome-targeting antibiotics. These values are chosen 
to be within the range of the literature values collated in [8]. The 
universal parameters are κ µ= × −6.1 10t 2  M −h 1, µ=r 19.3 Mmin    
and µ=r 65.8max   M [8, 20]. Except where stated otherwise, we have 
assumed an antibiotic-free growth rate λ0 of 1 −h 1.
Parameter
Value for 
low-affinity 
antibiotic
Value for 
high-affinity 
antibiotic
Pin 2000 −h 1 1 −h 1
Pout 100 −h 1 0.01 −h 1
kon 1000 μ −M 1 
−h 1
1000 μ −M 1 −h 1
koff 105  −h 1 10 −h 1
λ κ=∗ P k k2 t0 out off on/ 49.4 −h 1 0.004 93 −h 1
λ= −∗ ∗ r r PIC 250 0 max min in( )/( ) 0.574 μM 0.115 μM
Predicted IC50  
(from equation (8))
1.43 μM 11.64 μM
12 Literature values for kinetic parameters for tetracycline, 
chloramphenicol, streptomycin and kanamycin are reviewed 
in the supplementary material of [8].
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nature of its trajectories for values of aex
final below and 
above the bifurcation point. If aex
final is below the bifur-
cation point, as for the black trajectory in figure 4(b) 
(for = ×a 0.9ex
final   IC50), the dynamics approaches 
a fixed point which is close to the initial state, and in 
which the intracellular antibiotic concentration is 
small. This corresponds to the upper stable fixed point 
in figure 2(b). However, if aex
final is above the bifurcation 
point, as for the blue trajectory (for = ×a 1.1ex
final   IC50), 
the dynamics instead approaches a very different state, 
with a far higher intracellular antibiotic concentration 
and with ru close to µ=r 19.3min   M: this corresponds 
to the lower fixed point in figure 2(b), with essentially 
no growth.
The flow diagrams of figures 4(c) and (d) illustrate 
the two stable fixed points of the model dynamics for 
values of aex below the bifurcation point. These dia-
grams show the flow field r r,u b˙ ˙  for = ×a 0.9ex   IC50, for 
two different values of the intracellular antibiotic con-
centration a. In figure 4(c), the flow field is shown for 
µ=a 0.016  M, which corresponds to the final point 
of the black trajectory in figure 4(b) (this trajectory is 
also shown, projected onto the µ=a 0.016  M plane). 
The model has a stable fixed point for values of ru and 
rb which are close to the starting point of the trajec-
tory (i.e. the system state in the absence of antibiotic). 
The second stable fixed point is evident in figure 4(d), 
which shows the flow field for µ=a 200  M. This fixed 
point occurs at a much smaller value of ru ( ≈r ru min) 
and a higher value of rb. Interestingly, as for the low-
affinity case (figure 3(c)), the flow diagrams of figure 4 
show a separation of timescales between the rapid 
dynamics of transport and binding and the slower 
dynamics of ribosome synthesis. However the separa-
tion is less extreme than for the low-affinity case (since 
Pin, Pout and koff are all smaller)—this may explain why 
the approach to the stable state is monotonic rather 
than non-monotonic for our high-affinity parameter 
set.
Figure 5 compares directly the predictions of the 
model for a step increase in antibiotic concentra-
tion, for the low-affinity antibiotic (shown in red) 
and the high-affinity antibiotic (shown in blue), for 
antibiotic concentrations = ×a 0.5ex
final   IC50 and 
= ×a 1.5ex
final   IC50. The low-affinity antibiotic pro-
duces faster growth inhibition than the high-affinity 
antibiotic. For concentrations of antibiotic below 
the IC50 (figure 5(a)), the low-affinity antibiotic also 
achieves stronger inhibition at long times, for the 
‘equivalent’ concentration. However, for antibiotic 
concentrations above the IC50 (figure 5(b)), the final 
degree of inhibition is greater for the high-affinity 
Figure 3. Dynamical trajectories showing growth inhibition after a step increase in antibiotic concentration, for the low-affinity 
parameter set (with parameter values as in table 1). (a) Relative growth rate λ λt 0( )/  as a function of time after the step increase in 
antibiotic concentration. The final antibiotic concentration aex
final is indicated by the line colour, ranging from ×0.4  IC50  
(purple) to ×1.3  IC50 (red), in steps of ×0.1  IC50. (b) Trajectory in the 3-dimensional space of variables a, ru and rb, for the case of 
a step increase to = ×a 2ex
final   IC50. The initial and final system states are shown by the green and red points respectively. (c) Flow 
diagram showing the direction and magnitude of the flow field r r,u b˙ ˙  for a fixed value of a corresponding to the final point of the 
trajectory in panel (b), and for = ×a 2ex   IC50. The thin solid line shows the nullcline corresponding to =r 0u˙ ; this is given by 
κ κ λ= − − ∆ + − ∆k r r r k a r r r rt toff b u min on u min 2
2
0( )( ) ( ) / . The other nullcline, defined by =r 0b˙ , is not shown here. The trajectory 
from (b), projected onto the r r,u b plane, is shown as the thicker solid line.
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antibiotic. This  difference in final inhibition level 
arises from the behaviour of the fixed points of the 
model as a function of antibiotic concentration (figure 
2). For concentrations below the IC50, the stable fixed 
point for the low-affinity param eter set has a lower 
growth rate than that for the high-affinity parameter 
set, but for concentrations above the IC50, the situation 
is reversed (figure 2, compare (a) and (b)).
Time to full inhibition
From a practical point of view, it is important to 
know the time required to achieve maximal growth 
inhibition following an antibiotic dose. Because the 
variables in our model are continuous, the growth rate 
never completely reaches zero, but as a proxy for full 
inhibition we measure the time taken to achieve 99% 
inhibition, i.e. to reduce the growth rate to 1% of its 
Figure 4. Dynamical trajectories showing growth inhibition after a step increase in antibiotic concentration, for the high-affinity 
parameter set (with parameter values as in table 1). (a): Relative growth rate λ λt 0( )/  as a function of time after the step increase in 
antibiotic concentration. The final antibiotic concentration aex
final is indicated by the line colour, ranging from ×0.4   IC50 (purple) to 
×1.3   IC50 (red), in steps of ×0.1   IC50. (b): Trajectory in the 3-dimensional space of variables a, ru and rb, for the case of a step increase 
to = ×a 0.9ex
final   IC50 (black line) and = ×a 1.1ex
final   IC50 (blue line). The initial and final system states are shown by the green and red 
points respectively. (c): Flow diagram showing the direction and magnitude of the flow field r r,u b˙ ˙  for a fixed value of a corresponding 
to the final point of the black trajectory in panel (b), and for = ×a 0.9ex   IC50. The thin solid line shows the nullcline =r 0u˙ , given 
by κ κ λ= − − ∆ + − ∆k r r r k a r r r rt toff b u min on u min 2
2
0( )( ) ( ) / . The trajectory from (b), projected onto the r r,u b plane, is shown as the 
thick solid line. (d): Flow diagram showing the flow field r r,u b˙ ˙  for a fixed value of µ=a 200  M and for = ×a 0.9ex   IC50. The nullcline 
=r 0u˙  is shown by the thin solid line.
Figure 5. Dynamical trajectories showing growth inhibition after a step increase in antibiotic concentration, for the high-affinity 
and low-affinity parameter sets (blue and red lines, respectively, with parameter values as in table 1). (a) Predictions for a step 
increase to a final antibiotic concentration equal to half the IC50. (b) Equivalent predictions for a final antibiotic concentration equal 
to ×1.5  IC50. Note that the IC50 values are calculated as in table 1, and are different for the low and high-affinity antibiotics.
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antibiotic-free value: λ λ = 0.010/ . Although this is 
an arbitrary threshold, in a clinical situation a drastic 
reduction in bacterial population density is expected 
to lead to elimination of an infection, due to the 
action of the immune system [31]. In our model, 99% 
inhibition only occurs for higher concentrations of 
antibiotic; for lower concentrations the system instead 
reaches a steady state with a growth rate greater than 
λ×0.01 0 (as shown in figures 3(a) and 4(a)).
Figure 6 shows the time to reach λ λ= ×0.01 0, as 
a function of the antibiotic concentration, for the low-
affinity and high-affinity antibiotics. As expected, 
higher antibiotic concentrations lead to more rapid 
growth inhibition. For the low-affinity antibiotic 
(figure 6(a)), a high concentration is needed to achieve 
99% inhibition (∼ ×35 IC 50), but for these concentra-
tions, 99% inhibition is achieved very rapidly, on a 
timescale of minutes, and the inhibition time decreases 
smoothly as the antibiotic concentration increases. 
This is consistent with the inhibition trajectories 
shown in figure 3(a), which show a rapid initial inhibi-
tion of growth. For the high-affinity antibiotic (figure 
6(b)), 99% inhibition is achieved for much lower con-
centrations of antibiotic, just above the IC50, but the 
timescale for inhibition is longer, of the order of hours 
for concentrations close to the IC50. This is consistent 
with the inhibition trajectories of figure 4(a), which 
show very long timescales for inhibition for antibiotic 
concentrations close to the bifurcation point of the 
model dynamics. As we discuss in appendix B (and 
illustrate in figure B1), this very slow inhibition occurs 
because of a ‘bottleneck’ effect, in which dynamical 
trajectories slow down as they pass close to the location 
where the two fixed points have merged.
For the high-affinity antibiotic, it is possible to 
obtain an analytical prediction for the time to achieve 
99% inhibition, by making an adiabatic approximation 
for the dynamics of the intracellular antibiotic concen-
tration a t( ). This calculation is presented in detail in 
appendix B; briefly, we assume that the dynamics of 
a t( ) are fast compared to those of the other variables, 
and set =a 0˙  in equations (1)–(3). This reduces the 
model to a set of dynamical equations for ru and rb, and 
setting =k 0off  (for an irreversible antibiotic) decou-
ples these equations, allowing one to solve for ru, and 
hence for the growth rate λ t( ) via the constraint (4). 
Figure 6(b) shows that the resulting analytical predic-
tion for the inhibition time (red symbols) is in good 
agreement with the numerical results (black solid line).
Response to a step pulse of antibiotic
In a clinical situation, antibiotic treatment has a 
finite duration. The antibiotic concentration at the 
infection site increases after a dose is given and later 
decreases due to removal of the antibiotic from the 
body (the pharmocokinetic curve [15]). To mimic this, 
we investigate the response of the model to pulses of 
antibiotic of finite duration. We obtain predictions for 
the dynamics of the bacterial growth rate during and 
after the dose, for low- and high-affinity antibiotics, 
and for different dose durations and intensities. For 
simplicity, we first consider a step pulse of antibiotic 
of intensity S that is maintained for a fixed time T, 
as illustrated in figure 7(a); later we also consider a 
more clinically realistic scenario where the antibiotic 
is removed more gradually. We compare results for a 
fixed total antibiotic dose (duration  ×  intensity)—i.e. 
we compare the effect of a short, high-intensity dose 
with that of a long, low-intensity dose. Specifically, we 
fix × = ×S T 4   IC50. Although this choice is arbitrary, 
we find qualitatively similar results for other values of 
the total dose.
Low-affinity antibiotic: growth-rate overshoot  
following antibiotic removal.
Figure 7(b) shows model predictions for the bacterial 
growth rate, during and after a step-like pulse of a 
low-affinity antibiotic. The colours indicate doses 
of varying duration (as shown by the bars). During 
the dose, bacterial growth is suppressed, to a degree 
that depends on the intensity of the dose (the short, 
high intensity dose shown by the blue line causes a 
Figure 6. Model predictions for the time required to reach 99% growth inhibition λ λ = 0.010/ , following a step increase in 
antibiotic concentration. The inhibition time is plotted as a function of the external antibiotic concentration (note that the time 
is measured in minutes in (a) but in hours in (b)). Panel (a) shows results for the low-affinity antibiotic; panel (b) shows results 
for the high-affinity antibiotic (using parameters as in table 1); here the numerical solution of the model is shown by the solid line 
while the red symbols show the analytical prediction based on the adiabatic approximation, described in appendix B. For antibiotic 
concentrations lower than those plotted here, the dynamical trajectory of λ λ0/  always stays above 0.01.
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greater degree of growth inhibition than the long, low 
intensity dose shown by the red line). Interestingly, 
the model also predicts a ‘growth rate overshoot’ 
phenomenon: a peak in λ t( ) after the antibiotic dose 
ends, implying a transient increase in growth rate 
above the antibiotic-free steady-state value λ0. The 
overshoot occurs because, in our model, ribosome 
synthesis is upregulated during exposure to the 
antibiotic (s is larger, according to equation (6)), 
such that the total ribosome concentration becomes 
higher than it would be in the absence of antibiotic. 
Once the external antibiotic is removed, intracellular 
antibiotic dissociates rapidly from bound ribosomes, 
since  λkoff 0, so that the free ribosome pool becomes 
transiently larger than it would have been in the 
absence of antibiotic. In our model, this produces a 
Figure 7. Growth inhibition in response to a transient step-like dose of antibiotic. (a) Illustration of the dosing protocol:  
antibiotic concentration is switched suddenly to a value S at the start of the dose, and is switched back to zero after a time T. The 
total dose ×S T is fixed at ×4   IC50. (b) Growth-rate trajectories for the low-affinity antibiotic (with parameters as in table 1). 
The coloured lines represent doses of different duration and intensity (keeping the total dose fixed at ×4   IC50). The colour bars 
show the duration of the dose. The green and red dots correspond to the start and end points of the trajectory in panel (c). (c): 
Trajectory in the 3-dimensional space of variables a, ru and rb, after removal of the low-affinity antibiotic, for = ×S 2   IC50. The 
green point corresponds to the time immediately before the antibiotic is removed and the red point corresponds to a much later time 
( ∞t→ ) - as shown in panel (b). (d) Growth-rate trajectories as in panel (b), but for the high-affinity antibiotic (with parameters 
as in table 1). (e) Schematic illustration of hysteresis in the model for the high-affinity antibiotic. The response to a low-intensity 
pulse of antibiotic is shown by the red line: upon addition of antibiotic the system tracks the upper stable fixed point and reverses 
its trajectory when the antibiotic is removed. The response to a high-intensity pulse is shown by the blue lines: upon addition of 
antibiotic the system transitions to the lower stable fixed point, and it tracks the lower fixed point when antibiotic is removed.  
(f) Time taken to recover from a step dose of antibiotic, as a function of the duration of the dose. The solid line shows results for the 
low-affinity antibiotic, the symbols show results for the high-affinity antibiotic. Here, ‘recovery’ is defined to mean that the growth 
rate λ returns to a value λ×0.9 0, having previously fallen below this threshold. The recovery time is defined as the total time during 
which the growth rate is suppressed below λ×0.9 0.
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transient increase in growth rate. This is illustrated in 
figure 7(c), which shows a trajectory in the 3d space 
a r r, ,u b{ } after removal of the antibiotic, for a pulse 
with intensity = ×S 2 IC 50. The transient increase in 
unbound ribosome ru (and hence in growth rate) is 
coupled to loss of intracellular antibiotic a and bound 
ribosomes rb. The later decrease in ru back to the drug-
free steady state value (red dot in figure 7(c)) happens 
along the ru axis, once a and rb have both reached zero.
The magnitude of the transient growth-rate 
increase shown in 7(b) is greatest at intermediate 
antibiotic dose duration; this is because for very short 
antibiotic pulses, the bacterium does not have time 
to increase its ribosome pool significantly before the 
pulse ends, while for very long, low intensity pulses 
the antibiotic concentration is not high enough to 
produce a significant upregulation of ribosome con-
centration. Consistent with this explanation, when we 
repeat our simulations keeping the dose intensity fixed 
(i.e. increasing total dose as the duration increases), we 
find that the maximal overshoot occurs for the longest 
dose duration (data not shown).
Upregulation of ribosome synthesis upon exposure 
to antibiotic is a growth medium-dependent phenom-
enon: for bacteria growing in a poor medium (with a 
small drug-free growth rate λ0), the relative increase of 
the ribosome synthesis rate is larger than for bacteria 
growing on rich medium (with a large λ0) [20]. This is 
captured by the λ0-dependence of the synthesis rate s 
in our model (equation (6)). We therefore expect that 
the magnitude of the growth-rate overshoot predicted 
by the model will be medium-dependent, with a larger 
overshoot for bacteria growing on poor medium, which 
upregulate ribosome synthesis more strongly and there-
fore have a greater excess of ribosomes after the pulse. 
Indeed, upon repeating our calculations for a range of 
values of λ0, we observe a strong λ0-dependence of the 
magnitude of the overshoot. For example, for a dose of 
duration σ = 7 h, the growth rate at the peak of the over-
shoot is predicted to be λ λ = 2.3, 1.7, 1.30/ , for drug-
free growth rates of λ = 0.5, 1.0, 1.50  −h 1 respectively.
High-affinity antibiotic: post-antibiotic growth  
suppression and hysteresis.
Figure 7(d) shows equivalent predictions for the 
growth-rate response to a step pulse of high-affinity 
antibiotic. Here we observe a different phenomenon: 
the qualitative nature of the response is intensity-
dependent. For long-duration, low-intensity doses 
the growth rate is suppressed during the dose but 
recovers quickly when the antibiotic is removed (red-
green curves in figure 7(d)). However, for shorter, 
high intensity doses, the model shows a significant 
post-antibiotic effect: the growth rate decreases almost 
to zero during the dose and does not recover until 
many hours after the dose has ended (blue curves in 
figure 7(d)). This phenomenon arises from hysteresis 
in the model. When antibiotic is added, the fixed points 
of the model move along the aex axis in figure 2(b). As 
illustrated in figure 7(e), for a low-intensity antibiotic 
dose, the system tracks the upper stable fixed point and 
reverses its trajectory when the antibiotic is removed 
(red line in figure 7(e)). This corresponds to the red-
green trajectories in figure 7(d). However, for a high-
intensity antibiotic dose, the system is pushed past the 
bifurcation point in figure 2(b), forcing it to transition 
to the lower stable fixed point in which the growth rate 
is close to zero. When the antibiotic is removed, the 
system moves back along the lower line of fixed points, 
before eventually transitioning back to the upper fixed 
point (blue lines in figure 7(e)). The timescale over 
which this eventual recovery happens is controlled by 
the antibiotic-ribosome dissociation rate constant koff, 
which is small for the high-affinity antibiotic. Although 
we always see eventual recovery of the bacterial growth 
rate in our simulations, in a clinical setting we expect 
that other factors, such as immune response, would 
lead to elimination of the infection [31].
Optimal dosing strategy differs for low and  
high-affinity antibiotics.
In a clinical setting, antibiotic dosing protocols target 
different features of the pharmacokinetic curve: 
some are designed to maximise the peak antibiotic 
concentration, while others aim to maximise the time 
the concentration is above a threshold, or the area of 
the curve above the threshold [15, 32]. Although our 
simulated step-like dosing protocol (figure 7(a)) is 
simplistic, we do see clear differences in optimal dosing 
strategy for low-affinity and high-affinity antibiotics. 
These differences are illustrated in figure 7(f), where we 
plot the time required for the bacterial growth rate to 
recover from a step-like antibiotic dose, as a function 
of the duration of the dose (and hence its inverse 
intensity, as shown on the upper horizontal axis). Here, 
we define time to recovery as the time taken for the 
growth rate λ to recover to 90% of its antibiotic-free 
steady state value λ0, having previously fallen to below 
this value. For the low-affinity antibiotic (figure 7(f), 
solid line), the recovery time is proportional to dose 
duration: this is consistent with the growth inhibition 
trajectory (figure 7(b)), in which growth is suppressed 
during the dose and recovers rapidly afterwards. 
Therefore, for ribosome-targeting antibiotics which 
bind with low affinity and/or are transported reversibly, 
the model suggests that an optimal protocol would 
maximise the time over which the dose is maintained 
above a threshold. This is consistent with the fact 
that tetracycline antibiotics, which fall into the low 
affinity class in [8], are categorized in the clinical 
pharmacodynamic literature as time-dependent, i.e. 
the duration of the dosage controls efficacy of treatment 
[33]. In contrast, for the high-affinity antibiotic (figure 
7(f), symbols), the model predicts that the recovery 
time increases dramatically, to many times longer 
than the dose, when the dose intensity exceeds a well-
defined threshold (i.e. for shorter dose durations in our 
simulations). This is also consistent with the growth 
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inhibition trajectories of 7(d). Thus our model suggests 
that for ribosome-targeting antibiotics which bind 
with high affinity and/or are transported irreversibly, 
it may be more important to maximise the peak 
concentration of the pharmacokinetic curve than the 
duration of the dose. This prediction is consistent with 
the fact that aminoglycoside antibiotics, which fall into 
the high-affinity class in [8], are categorized clinically as 
concentration-dependent, i.e. the peak concentration 
controls the treatment efficacy [33]. Our predictions are 
also consistent with the fact that aminoglycosides can 
show significant post-antibiotic effects [17–19, 32, 34].
Response to a more realistic pulse of antibiotic
In a clinical scenario, the antibiotic concentration in 
the body decreases gradually after a dose, rather than 
suddenly. The pulse profile shown in figure 8(a), in 
which the concentration increases very rapidly, but 
decreases exponentially with a decay time Tx, could 
mimic a dose that is given intravenously and removed 
by metabolism/excretion. We therefore simulated the 
response of our model to such a pulse, represented by the 
function = − −a t S t t Texpex x 0 x( ) [ ( )/ ] for > =t t 30  
h, and =a 0ex  otherwise. We varied the duration Tx, 
keeping the integrated dose constant: = ×S T 4x x   IC50.
Figure 8(b) shows results for the low-affinity anti-
biotic. As for the step pulse, the bacterial growth rate is 
suppressed during the pulse, to an extent that depends 
on pulse intensity (the longer, less intense pulse shown 
by the red curve produces longer duration but weaker 
growth suppression than the shorter, more intense 
pulse shown by the blue curve). The model also predicts 
the same growth-rate overshoot phenomenon for the 
exponentially decaying pulse which we observed for the 
step pulse. However, the growth-rate overshoot only 
happens if the pulse decays quickly enough; for slowly-
decaying pulses (large Tx), the overshoot is masked by 
the growth-rate suppression due to the antibiotic.
The response to an exponentially-decaying pulse 
of a high-affinity antibiotic (figure 8(c)) is also quali-
tatively similar to that for the step pulse (figure 7(d)). 
As for the step pulse, for pulses of intensity below a 
threshold value, the growth rate recovers quickly fol-
lowing the antibiotic dose. However for pulses with 
intensity above the threshold, there is a post-antibiotic 
effect, in which growth suppression persists for long 
times after the antibiotic has been removed (longer 
than those shown in figure 8(c)).
Figure 8(d) shows the predicted recovery time 
after an exponentially-decaying pulse of antibiotic, 
defined as the time to recover to λ λ= 0.9 0. For the 
low-affinity antibiotic (solid line in figure 8(d)), the 
time to recovery increases with the dose duration. This 
supports our prediction that for the low-affinity anti-
biotic, dose duration is the key determinant of treat-
ment efficacy. For the high-affinity antibiotic (symbols 
in  figure 8(d)), the time to recovery shows qualita-
tively similar behaviour to that for the step-like pulse 
Figure 8. Growth inhibition in response to an exponentially-decaying dose of antibiotic. (a): Illustration of the dosing protocol. 
The total dose S Tx x is fixed at ×4   IC50. (b) Results for the low-affinity antibiotic, with parameters as in table 1. The coloured lines 
represent doses of different duration and intensity, from =T 0.1x  h (blue) to =T 2.2x  h (red), keeping the total dose fixed. The colour 
bars show the dose duration Tx. (c) Results for the high-affinity antibiotic, with parameters as in table 1. Colours are as in (b). (d) 
Time taken to recover from a step dose of antibiotic, as a function of the duration / intensity of the dose. ‘Recovery’ is defined as an 
increase in λ t( ) to a value λ0.9 0, having previously been below this threshold. The recovery time is defined as the total time during 
which the growth rate is suppressed below λ×0.9 0. The solid line shows results for the low-affinity antibiotic, the symbols show 
results for the high-affinity antibiotic.
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(compare to figure 7(f)), in that the time to recovery is 
very long for short, intense pulses, but decreases dra-
matically for pulses with intensity below a threshold.
We have also performed equivalent simulations 
for a Gaussian pulse profile, with qualitatively similar 
results (see appendix C).
Taken together, these results show that the phenom-
ena predicted by our model: (i) duration- dependent 
efficacy for ribosome-targeting antibiotics which bind 
with low affinity and/or are transported reversibly, (ii) 
possible growth-rate overshoot for these ‘low-affinity’ 
antibiotics, (iii) peak intensity- dependent efficacy for 
ribosome-targeting antibiotics that bind with high 
affinity and/or are transported irreversibly and (iv) 
post-antibiotic effect for these ‘high-affinity’ antibiot-
ics, are all independent of the details of the antibiotic 
dosage protocol.
Discussion
In this paper, we have studied the dynamical response 
of bacterial growth rate to sustained and transient 
antibiotic treatment, for ribosome-targeting antibiotics. 
The model that we have used is simple: it includes only 
antibiotic-ribosome binding, antibiotic transport, 
growth, and ribosome synthesis, with the latter two 
processes being dependent on the state of the system. 
In previous work [8], this model has been shown to 
predict qualitatively different steady-state behaviour 
for two classes of ribosome-targeting antibiotics: ‘low-
affinity’ antibiotics which bind to ribosomes with low 
affinity and/or are transported reversibly across the cell 
boundary, and ‘high-affinity’ antibiotics which bind 
with high affinity and/or are transported irreversibly.
Here, we go beyond the steady-state analysis of [8], 
to investigate the response of the model to dynamical 
changes in antibiotic concentration. Our results show 
that low-affinity and high-affinity ribosome-targeting 
antibiotics show qualitatively different dynamical 
responses to antibiotic treatment. Low-affinity anti-
biotics show a non-monotonic response, with a rapid 
decrease in growth rate upon exposure to antibiotic, 
followed by a slower partial recovery mediated by up-
regulation of ribosome synthesis. Up-regulation of 
ribosome synthesis during exposure also means that 
these antibiotics may show a growth rate overshoot 
upon removal of the antibiotic. In contrast, high-
affinity antibiotics show a concentration-dependent 
response: upon antibiotic exposure, the growth rate 
decreases very little if the antibiotic concentration is 
below a threshold given by the bifurcation point of 
the model dynamics, but it decreases almost to zero 
upon exposure to antibiotic concentrations above the 
threshold. Close to the threshold concentration the 
time taken to reach this maximal inhibition can, how-
ever, be very long: this behaviour can be understood 
by the fact that the dynamical trajectories of the model 
slow down as they pass close to the location where the 
two fixed points have merged. Furthermore, the model 
predicts a pronounced post-antibiotic suppression of 
growth upon removal of a high-affinity antibiotic, for 
concentrations above the threshold—a phenomenon 
that results from hysteresis in the model dynamics.
Mathematical models that integrate the molecular 
mechanism of antibiotic action with bacterial physi-
ology are rare, and those that do exist mostly consider 
only the response to a time-invariant antibiotic con-
centration [2, 7–10]. Of those that do consider time- 
dependent doses of antibiotic, probably the recent work 
of Abel zur Wiesch et al [11, 12] is closest to ours. In that 
study, a genetic model for antibiotic transport and target 
binding is considered, and shown to reproduce a range 
of pharmacodynamic phenomena. However, target-spe-
cific physiology (here, the interplay between ribosome 
concentration and growth rate) is not considered. Here 
we show that this interplay can play a key role, leading 
to qualitatively new features such as growth-medium 
dependent responses and growth-rate overshoots.
Are the predictions of our model realistic? Of course 
many factors have not been included in the model. For 
example, we have assumed throughout that growth 
rate is determined solely by the active ribosome abun-
dance, via equation (4). Although this relation is well-
established for steady-state growth, other factors may 
come into play during transient growth-rate change. 
In particular, the growth rate may become limited by 
the supply of amino acids rather than by the abun-
dance of free ribosomes. This might tend to suppress 
the growth-rate overshoot predicted by our model for 
the low-affinity antibiotics. More specifically, during an 
antibiotic pulse, when translation is inhibited, the total 
ribosome abundance is close to maximal ( ≈r rtot max in 
equation (5)). According to the proteome partitioning 
model, this increased production of ribosomes comes at 
the expense of producing metabolic enzymes necessary 
for amino acid supply [20, 26]. Thus, when the antibi-
otic is removed and ribosomes are released, there may 
be a transient period when the rate of growth is limited 
by amino acid supply, before metabolic enzymes are re-
synthesized to restore the balance between amino acid 
influx and the demands of translating ribosomes [26]. 
In this scenario, we would still expect an overshoot in 
the total ribosome concentration upon removal of the 
antibiotic, but this might not be coupled to an increase 
in growth rate. Our model also neglects any other effects 
of the antibiotics on bacterial physiology: for example, 
aminoglycosides are believed to increase membrane 
permeability through the production of misfolded pro-
tein [35]. In addition, we do not model bacterial killing, 
either directly by antibiotic action, or indirectly via the 
body’s immune system [31]. Inclusion of these killing 
effects in the model would be likely to prevent the long-
time recovery dynamics predicted here for the high-
affinity antibiotics.
To conclusively assess the realism of the predictions 
reported here, one would need experimental tests. Sev-
eral recently-developed bacterial growth techniques 
make such tests feasible. At the level of bulk cultures, 
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continuous culture devices have been developed that 
allow measurement of growth rate during time-depend-
ent antibiotic exposure [28, 36]. Interestingly, turbi-
dostat data for Enterococcus faecalis populations exposed 
to a sudden influx of the ribosome-targeting antibiotic 
tigecycline, which is expected to be in the low-affinity 
class, does show rapid growth rate suppression followed 
by slower partial recovery, as predicted by our model 
(see figure 1C of [29])13. At the level of individual cells, 
microfluidic devices in which the antibiotic concentra-
tion can be changed rapidly as growth is monitored in a 
microscope are also now possible [30]. The latter would 
be an especially interesting approach since the bistability 
which is manifested in our model for high-affinity anti-
biotics might lead to heterogeneous responses to antibi-
otic exposure among cells in a population.
If confirmed experimentally, the phenomena 
reported here would be of considerable clinical signifi-
cance. In particular, our results make a clear prediction for 
the optimal pharmacodynamic strategy: for low-affinity 
drugs one should aim to maximise the time of exposure, 
while for high-affinity drugs, one should aim to maxim-
ise the peak dosage. Moreover, the latter are predicted to 
show a pronounced post-antibiotic effect, meaning that 
they can be effective for much longer than the actual 
duration of exposure. Post-antibiotic effects are a widely 
recognised, but poorly understood, pharmacodynamic 
phenomenon, and occur for various antibiotics including 
aminoglycosides [17–19]. Our work suggests that models 
that integrate molecular mechanism with bacterial cell 
physiology can be a useful tool for understanding such 
clinically relevant growth inhibition phenomena and 
thus, potentially, for helping to improve clinical practice.
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Appendix A. Bifurcation points of the 
model
As we show in figure 2, the model described by 
equations (1)–(3) may have different numbers of 
stationary points (stable and unstable fixed points), 
depending on the parameter values. Changes in the 
number and character of the fixed points of the model 
occur at critical parameter values, and are known as 
bifurcation points. Figure A1 illustrates these bifurcation 
points in more detail. Here we use a parameter set 
intermediate between the low and high-affinity cases 
studied in the rest of the paper: =P 1in  −h 1, =P 1out  
−h 1, µ=k 1000on   −M 1 −h 1. We vary the parameter koff 
and plot the fixed points of the model as a function of 
a Pex in. Figure A1(a) shows results with =k 1000off  
−h 1, for which there is only a single fixed point. In 
contrast, for a smaller value of =k 100off  −h 1, as shown 
in figure A1(b), for some values of a Pex in the model has 
one fixed point (which is stable), and for other values 
of a Pex in there are three fixed points, two of which are 
stable and one unstable. The regime in which there are 
three fixed points is bistable (shaded) and is bounded 
by two bifurcation points, labelled ∗aex,low and 
∗aex,high in 
figure A1(b), where the number of fixed points changes. 
The upper bifurcation point ∗aex,high is associated 
with a steep decrease in the growth rate λ, since at this 
bifurcation point the upper stable fixed point is lost and 
λ drops to the lower fixed point. This critical value ∗aex,high 
is very close to (though not exactly equal to) the IC50.
The bifurcation points can be calculated by not-
ing that the fixed points of the model dynamics are 
given by the roots of equation (7). The number of 
roots — and thus the number of fixed points—is 
determined by the discriminant of equation (7): if 
the discriminant is positive there are three roots, 
otherwise, there is only one root. Thus the zeros 
of the discriminant mark the bifurcation points. 
Since equation (7) is a cubic equation in λ, it may be 
written as λ λ λ+ + +a b c d3 2 , with discriminant 
∆ = − − − +b ac b d a d abcd4 4 27 182 3 3 2 2 . The zeros 
of the discriminant can be computed numerically. 
Figure A1(c) shows the results of such a computation: 
here the bifurcation points ∗aex,low and 
∗aex,high are plot-
ted as a function of koff. Since the discriminant itself is 
cubic in aex it may have either one or three zeros; those 
at positive aex correspond to 
∗aex,low and 
∗aex,high
14. For 
low values of koff there are two bifurcation points as 
in figure A1(b), while for high values of koff there is no 
bifurcation, as in figure A1(a).
We can also obtain an analytical estimate for the 
upper bifurcation point = ∗a aex ex,high, which corre-
sponds to the antibiotic concentration at which the 
model predicts a threshold drop in growth rate. To this 
end, we rewrite equation (7) in the form
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎡
⎣⎢
⎛
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λ
λ
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λ
λ
λ λ
λ
λ
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+ −
+ + + −
− + −
−
k P
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k P k
P k P k
P k
0
1
1
1 1 1
1 1 1
1
,
t
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ex in
0
2
on out off 0
out 0 off 0 out off
2
out off 0
3
 
(A.1)
13 The antibiotic used in figure 1C of [29] is tigecycline 
(Kevin Wood, personal communication).
14 There is also one unphysical zero point of the discriminant 
at negative values of aex not shown here.
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(note that we have multiplied equation (7) by a factor 
of 4). Interestingly, this equation depends only on 
the combination a Pex in rather than on aex and Pin 
independently. This is why we have used the parameter 
combination a Pex in in figure A1; it also implies that the 
critical values ∗aex scale as ∼
∗a P1ex in/ . For  κk ton , and 
k Poff out not too large, the second term in equation (A.1) 
can be neglected and we arrive at the quadratic equation
λ
λ
λ=
∆
+ +
a P
r
0
1
.ex in
0
2
 (A.2)
The zero of the discriminant is then at
λ
=
∆∗a P
r
4
.ex in
0
 (A.3)
Setting µ=r 19.3min   M, µ=r 65.8max   M, and λ = 10   
−h 1, as in table 1, this gives µ=∗a P 11.625ex in   M 
−h 1, shown in figure A1(c) as the blue dashed line. 
Figure A1(c) shows that for small values of koff this 
provides a very good estimate for the upper bifurcation 
point ∗aex,high. Thus, µ=
∗a 11.62ex   M −h 1/Pin is a good 
estimate for the threshold antibiotic concentration 
and the IC50 for high-affinity antibiotics. Remarkably, 
this approximation does not explicitly depend on 
Pout, koff or kon. For large values of koff or Pout, however, 
this approximation does not hold anymore, since the 
prefactor k P1 off out/( ) in equation (A.1) decreases the 
importance of the first term relative to the second 
term.
Appendix B. Analytical calculation 
of inhibition time for a high-affinity 
antibiotic using the adiabatic 
approximation
Incorporating expression (6) for the ribosome 
synthesis rate into the dynamical equations (1)–(3), 
our model can be expressed as:
λ= − − − + − +a a k r r a P a P a k ron u min in ex out off b˙ ( )
 (B.1)
λ λ λ= − − − + − +r r k r r a r c k ru u on u min max off b˙ ( ) ( )
 (B.2)
λ= − + − −r r k r r a k rb b on u min off b˙ ( ) (B.3)
where ∆ = −r rmax min, ≡∆ −λ κ ∆c r r
1 1
t0
( ) and λ is 
a function of ru via equation (4). Making the 
adiabatic approximation, i.e. setting =a 0˙ , and using 
equation (4) to eliminate ru, equation (B.1) gives
λ
=
+
+ +
κ
a
P a k r
P 1
.
k
in ex off b
out
t
on( ) (B.4)
Figure A1. Illustration of the bifurcation points of the model. (a) Growth rate as a function of a Pex in for =k 1000off  −h 1, =P 1in  −h 1, 
=P 1out −h 1 and µ=k 1000on   −M 1 −h 1. For this parameter set the system has one fixed point. (b) Growth rate as a function of a Pex in 
for =k 100off −h 1, =P 1in −h 1, =P 1out −h 1 and µ=k 1000on   −M 1 −h 1. Here, the system has regimes with one fixed point and a bistable 
regime with three fixed points (shaded area)—two of which are stable (solid lines) and one unstable (dashed blue line). The bistable 
regime is bounded by the critical values ∗aex,low and 
∗aex,high. (c) The critical points 
∗aex,low and 
∗aex,high, computed from the discriminant 
of equation (7) as detailed in the text and plotted as function of koff. The bistable regime is shaded. The blue dashed line marks the 
analytical estimate λ∆r 40/  for the upper critical point ∗aex,high, which is valid for  κk ton  and  λ ∆P k a P rout off ex in / . Note that since 
equation (7) is symmetric under exchange of koff and Pout, 
∗a Pex in as a function of Pout would look exactly the same for =k 1off  −h 1.
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Substituting equation (B.4) into equations (B.2) 
and (B.3) and using equation (4) to change variables 
from ru to λ, we obtain
( )
˙ ( ) ( )λ λ κ λ
λ
κ λκ
= − + −
+
+ +
+ +∆
κ
c
k P a k r
P
k r r
1
1
t
k
t t
2 on in ex off b
out
off b
t
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 (B.5)
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.t kb b on
in ex off b
out
off b
t
on
˙ /
( ) (B.6)
Starting from equation (B.5), we then make the 
approximation that λ κ+ k P1 ton out( / ) 15. Since 
we are dealing with a high-affinity antibiotic, we also 
set =k 0off . This allows us to express the model as an 
equation in one variable only (the growth rate λ t( )):
λ λ κ λκ= − + −
+
+∆
κ
c
k P a
r1
1
.t k t
2 on in ex
t
on
˙ ( )
( ) (B.7)
Returning to equation (B.7), we can integrate the 
trajectory λ t( ) to predict the time Tc required for λ to 
reach a predefined threshold λc:
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This integral can be solved using the substitution 
κ κ λ κ κ= ∆ − + + − ∆u r c c C r2 1 1 4t t t t 2/ ( ) ( ) ( ) / , 
where we have defined = + κC k P a 1
k
on in ex
t
on. This 
gives the following result:
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(B.9)
Setting λ λ= 0.01c 0 in equation (B.9) leads 
to the results shown as the solid curve in 
figure 6. Note that this integration is only valid 
if κ κ∆ − + <r c C4 1 0t t2( ) ( ) . Otherwise, the 
denominator becomes zero and Tc diverges. This 
would be the case if the system is at the upper stable 
fixed point of the dynamics, such that the growth rate 
is not significantly decreased upon exposure to the 
antibiotic.
This analysis also allows us to understand the origin 
of the very slow inhibition dynamics for the high-affin-
ity antibiotic, for values of aex just above the bifurca-
tion point, as shown in figure 4(a). Figure B1 shows the 
rate of change of the growth rate, λ˙, plotted as a func-
tion of λ, as predicted by equation (B.7), for the high-
affinity parameter set. Figure B1(a) shows results for 
= ×a 0.95ex   IC50 (just below the bifurcation point): 
the fixed points correspond to zeroes of λ˙ and the sta-
ble one is indicated by the arrow (there is of course also 
another stable fixed point at very small λ, but this is 
lost in the quadratic approximation of equation (B.7)). 
Figure B1(b) shows equivalent results for a slightly 
higher antibiotic concentration, = ×a 1.05ex   IC50, 
just above the bifurcation point. Here the fixed points 
are lost, but the rate of change of λ still comes close to 
zero, implying that the speed of inhibition by the anti-
Figure B1. Rate of change of growth rate λ˙, plotted as a function of λ, as given by the adiabatic approximation, equation (B.7).  
Panel (a) shows results for = ×a 0.95ex   IC50 (just below the bifurcation point of figure 2(b)), while panel (b) shows results for 
= ×a 1.05ex   IC50 (just above the bifurcation point).
15 We expect this approximation to be valid close to the 
upper fixed points, whose bifurcation we are concerned with 
here. Close to the lower stable fixed point, where λ 0→ , the 
approximation may not hold.
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biotic will be very slow. This slow dynamics close to the 
bifurcation point can be thought of as a ‘bottleneck’ in 
the inhibition trajectory.
Appendix C. Response to a Gaussian pulse 
of antibiotic
As an example of a dosage profile without any 
discontinuities, we also simulated the response of 
the model to a Gaussian pulse of antibiotic, of the 
form = − −a t S t t Texp 2ex g max 2 g
2( ) [ ( ) / ]  , as shown 
in figure C1(a). We varied the intensity Sg and the 
duration Tg, keeping the integrated dose, which 
is given approximately by pi S T2 g g( / ) , fixed at 
×4   IC50. The results are qualitatively similar to those 
for the step-dose and the exponentially decaying 
dose, described in the main text. For the low-affinity 
antibiotic, figure C1(b) shows that the bacterial growth 
rate is suppressed during the Gaussian pulse, to an 
extent that depends on pulse intensity, and we see the 
same growth-rate overshoot phenomenon following 
the Gaussian antibiotic pulse which we observed 
for the step and exponentially-decaying pulses. For 
the high-affinity antibiotic, figure C1(c) shows that 
for pulses of intensity below a threshold value, the 
growth rate recovers quickly following the antibiotic 
dose, but for pulses with intensity above the threshold 
growth suppression persists for long times after the 
antibiotic has been removed. Figure C1(d) shows 
the predicted recovery time after a Gaussian pulse of 
antibiotic, defined as the time to reach λ λ= 0.9 0. For 
the low-affinity antibiotic (solid line in figure C1(d)), 
the time to recovery increases with the dose duration, 
whereas for the high-affinity antibiotic (symbols in 
figure C1(d)), the time to recovery is very long for 
short, intense pulses, but decreases dramatically for 
pulses with intensity below a threshold. The more 
complex shape of the plot for low-intensity pulses, 
compared to the results for the step and exponentially-
decaying pulses, is due to the shape of the Gaussian 
pulse; for values of Tg above  ∼9 h, the growth rate no 
longer decreases below λ0.9 0.
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